User profiles for Jimmy D. Gollihar
 | Jimmy D Gollihar, PhDProfessor of Pathology & Genomic Medicine @ Houston Methodist Research Institute Verified email at houstonmethodist.org Cited by 2970 |
[HTML][HTML] Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma
…, BV Lopez, C Hampton, J Lavinder, JD Gollihar… - The American journal of …, 2020 - Elsevier
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma …
coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma …
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
The molecular composition and binding epitopes of the immunoglobulin G (IgG) antibodies
that circulate in blood plasma after severe acute respiratory syndrome coronavirus 2 (SARS-…
that circulate in blood plasma after severe acute respiratory syndrome coronavirus 2 (SARS-…
Coupling sensitive nucleic acid amplification with commercial pregnancy test strips
Y Du, A Pothukuchy, JD Gollihar… - Angewandte Chemie …, 2017 - Wiley Online Library
The detection of nucleic acid biomarkers for point‐of‐care (POC) diagnostics is currently limited
by technical complexity, cost, and time constraints. To overcome these shortcomings, we …
by technical complexity, cost, and time constraints. To overcome these shortcomings, we …
[HTML][HTML] Relationship between anti-spike protein antibody titers and SARS-CoV-2 in vitro virus neutralization in convalescent plasma
Newly emerged pathogens such as SARS-CoV-2 highlight the urgent need for assays that
detect levels of neutralizing antibodies that may be protective. We studied the relationship …
detect levels of neutralizing antibodies that may be protective. We studied the relationship …
Treatment of COVID-19 patients with convalescent plasma in Houston, Texas
…, BV Lopez, C Hampton, J Lavinder, JD Gollihar… - medRxiv, 2020 - medrxiv.org
Background COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent …
(SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent …
Building biosecurity for synthetic biology
…, DA Bleijs, MV Florin, JD Gollihar… - Molecular systems …, 2020 - embopress.org
The fast‐paced field of synthetic biology is fundamentally changing the global biosecurity
framework. Current biosecurity regulations and strategies are based on previous governance …
framework. Current biosecurity regulations and strategies are based on previous governance …
[PDF][PDF] Rapid characterization of spike variants via mammalian cell surface display
The SARS-CoV-2 spike protein is a critical component of vaccines and a target for neutralizing
monoclonal antibodies (nAbs). Spike is also undergoing immunogenic selection with …
monoclonal antibodies (nAbs). Spike is also undergoing immunogenic selection with …
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas
… Kinskey; Jimmy D. Gollihar. … Gollihar; CCDC Army Research Laboratory-South …
[HTML][HTML] SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode
The ongoing evolution of SARS-CoV-2 into more easily transmissible and infectious
variants has provided unprecedented insight into mutations enabling immune escape. …
variants has provided unprecedented insight into mutations enabling immune escape. …
[HTML][HTML] Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols
The yeast Saccharomyces cerevisiae is powerful for studying human G protein-coupled
receptors as they can be coupled to its mating pathway. However, some receptors, including the …
receptors as they can be coupled to its mating pathway. However, some receptors, including the …